The EU currently faces complex challenges regarding its internal unity, normative coherence and justifiable and universally acceptable refugee, migration, and integration policies. Convincing and successful responses require better knowledge on politically and socially relevant values, their impact on and transformation in migration/integration contexts and the role and possible evolution of European values. NOVAMIGRA – Norms and Values in the European Migration and Refugee Crisis will enhance the European knowledge base on these issues with a unique combination of social scientific and historical analysis, as well as legal and philosophical normative reconstruction and theory. It will provide a precise and comprehensive understanding of core values/norms in Europe, explain, how they motivate political, administrative and societal agents with regard to migration and the integration of migrants and refugees into European societies, and consider, if and why this has changed with and since the refugee crisis 2015. This will lead to better normative and efficiency assessments of migration/integration policies and measures, and to a clearer grasp of reasons for their endorsement or resistance to them. On this background NOVAMIGRA will develop a new idea[l] for Europe, a rights-based democratic perspective for the EU and its member states, which takes into account differences in European values/norms and their possible evolution and also reflects Europe’s global responsibility. This new idea(l) will allow design of a new political strategy for overcoming the deep divergences in Europe and inform NOVAMIGRA’s concrete policy recommendations contributing to the further development of the European Agenda on Migration, the Action Plan on the Integration of Third Country Nationals and similar European and national initiatives.
Background: Long term conditions require monitoring of patients, traditionally conducted in the clinic, to monitor treatment effects, adverse events and disease course. This can be inefficient and cumbersome – clinic visits may be too infrequent to identify individuals at risk of significant changes in disease state (e.g. relapse) and place unnecessary burden on patients and providers. Smartphone and wearable technologies have led to an exponential growth in the amount of information which can be collected on patients unobtrusively and at low cost. Sensors collect data passively, and active monitoring, using experience sampling, provides information on multiple parameters. Such technologies could monitor long term outcomes of patients, at scale, and provide fine-grained information on outcomes, available in real time and at low-cost, enabling services to offer more responsive and efficient care. Whilst there is growing interest in the application of RMT in health, the field is in its infancy. The private-public partnership fostered by IMI2 is an ideal way to overcome the inherent challenges of this field. Our ultimate goal is to improve patient outcomes through remote assessment. To achieve this we will create a pipeline for developing, testing and implementing RMT in depression, multiple sclerosis and epilepsy. The pipeline will include a data management and modelling infrastructure applicable to other disorders and with the flexibility of design to be future-proofed against further technological innovation. We will provide data on implementation barriers and facilitators gleaned from patients, clinicians, regulator and payers which will optimise the pathways for regulatory approval and uptake. Program of Work: In order to test the feasibility and predictive power of RMT four main components are required: (1) Excellent project oversight, management, and a dissemination and exploitation strategy;